Procter & GamblePGDON'T BUYJul 22, 2015Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
He would have to categorize this with a lot of other consumer package companies. They are good companies, but tend to struggle for a catalyst. They tend to be low single digit growers. In many, many cases they are trade at an exaggerated P/E ratio, in large part because of the dividends. They have offered higher dividends because they have predictability of cash flow. In the low interest rate environment it is very attractive, but interest rates are about to start to rise. High dividend payers will have less cache and the multiples are going to suffer.